(Q45807906)

16 December 2017

title

In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc (English)

1 reference

16 December 2017

author name string

James F Demarest

1

1 reference

16 December 2017

Sara S Sparks

2

1 reference

16 December 2017

Kathleen Schell

3

1 reference

16 December 2017

Shiro Shibayama

4

1 reference

16 December 2017

Charlene B McDanal

5

1 reference

16 December 2017

Lei Fang

6

1 reference

16 December 2017

Kimberly K Adkison

7

1 reference

16 December 2017

Anne Shachoy-Clark

8

1 reference

16 December 2017

Stephen C Piscitelli

9

1 reference

16 December 2017

publication date

1 August 2008

1 reference

16 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

16 December 2017

volume

48

1 reference

16 December 2017

issue

10

1 reference

16 December 2017

page(s)

1179-1188

1 reference

16 December 2017

Time trends in primary HIV-1 drug resistance among recently infected persons

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

The prevalence of antiretroviral drug resistance in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

The therapeutic potential of CXCR4 antagonists in the treatment of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Drug discovery: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Pharmacokinetics and short-term safety of 873140, a novel CCR5 antagonist, in healthy adult subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

A rapid and simple colorimetric test for the study of anti-HIV agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322178

21 January 2018

Identifiers

DOI

10.1177/0091270008322178

1 reference

16 December 2017

1 reference

16 December 2017